⁉️ What drives the selection of a JSC request? 
 

🔊 On Dec 9th European Commission finally published 10 guidance documents for EU HTA. Even though publication of Implementing Acts attracted much more interest, the guidance documents are the fine print that will decide on the details. Today we will take a closer look at the request of MPs for JSC (T01). Officially it is called "Request template for HTACG JSC and Parallel HTACG/EMA JSC for Medicinal Products (MP)".  

 

This is the information you have to provide: 

🔹 HTD and contact details 

🔹 Information on the medicinal product 

➡️ Note that there is no confirmation needed on meeting the criteria for JCA (even though this is a selection criteria (3) Ecker + Ecker GmbH: Administrator der Unternehmensseite | LinkedIn

🔹 Format of JSC requested (HTA JSC or parallel EMA / HTA JSC) 

🔹 Regulatory status 

🔹 Information on clinical trials (which are subject to JSC) 

🔹 Selection criteria according HTAR 

🔹 Scope / Area of advice 

📋 Includes a list of questions

 

 What's weird? 

🔹 Why to ask for the list of questions already - they are not relevant for the selection. Or are they?